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Abstract
Introduction: Sweet’s syndrome characterized by fever, blood neutrophilia and inflammatory skin lesions, is rarely
diagnosed in children. It presents in three clinical settings: classical Sweet’s syndrome, usually after a respiratory
tract infection; malignancy-associated, frequently related to acute myelogeneous leukemia; and drug-induced. We
present, to the best of our knowledge, the first case of a rotavirus -infection-related Sweet’s syndrome.
Case presentation: An 18-month-old boy of Hellenic origin was referred to us with diarrhea, fever, neutrophilia,
typical skin lesions, asymmetrical hip arthritis and oropharyngeal involvement. A skin biopsy confirmed the
diagnosis. Thorough screening did not reveal any underlying systemic illness, except for the confirmation of an
overt rotavirus infection. The syndrome responded promptly upon corticosteroid administration; no recurrence was
observed.
Conclusion: Besides describing the connection of Sweet’s syndrome to a rotavirus infection, this case report is also
a reminder that in a child presenting with a febrile papulo-nodular rash with neutrophilia Sweet’s syndrome should
be included in the differential.
Introduction
Sweet’s syndrome (acute febrile neutrophilic dermatosis)
is characterized by a constellation of clinical symptoms
and physical findings, which include fever, blood and
tissue neutrophilia, leading to the development of ten-
der, erythematous inflammatory skin lesions (papules,
nodules, plaques), histopathologically characterized by
the presence of abundant mature neutrophils [1]. It pre-
sents in three clinical settings: ‘classical’ (’para-infec-
tious’) Sweet’s syndrome, representing a hypersensitivity
reaction preceding infection; malignancy-associated
(’para-neoplastic’) Sweet’s syndrome (in children usually
associated with acute myelogenous leukemia); and less
frequently as an adverse drug reaction, sometimes in
connection with certain underlying diseases (drug-
induced Sweet’s syndrome) [2]. Irrespective of its cause,
clinical and laboratory signs in Sweet’ss y n d r o m e
respond promptly to systemic corticosteroids. Sponta-
neous resolution is possible, although a persisting recur-
rent course over months is the rule [3].
Sweet’s syndrome is rarely diagnosed in children [4].
Here, on the occasion of a child with classical, “para-
infectious” Sweet’ss y n d r o m ew ep r e s e n t ,t ot h eb e s t
of our knowledge for the first time in the accessible
literature, the association of this syndrome to a rota-
virus infection. The current report appends rotavirus
to the list of infectious agents associated with Sweet’s
syndrome, thus expanding the pertinent diagnostic cri-
teria [5].
Case presentation
An 18-month-old boy of Hellenic origin was initially
admitted to another hospital because of fever up to
39.9°C lasting for five days, a mild cough, one to two
vomits and two to three yellowish diarrheas per day. On
examination, apart from fever (38.8°C) no other patholo-
gical findings were present. Laboratory evaluation
revealed leukocytosis (26,500/μl) with 47% neutrophils
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(57 mm/1
st hour) and C-reactive protein (CRP)
(100 mg/l) (Table 1). Tests for infections were negative
except for the detection of a rotavirus antigen (immuno-
chromatographic test). The cultures from skin lesions
were negative. On day one of hospitalization a papulo-
nodular rash with lesions of up to 2 cm in diameter,
some of them with central ulceration, appeared on the
trunk and extremities. The child remained febrile and in
the following days new crops of similar skin lesions
erupted, while blood neutrophilia and elevated ESR and
CRP persisted. On day six a restriction of the sponta-
neous movements of the left hip, indicative of underly-
ing arthritis was added to his clinical picture, however,
without corresponding pathological findings in X-ray
and ultrasound imaging. Because of the clinical suspi-
cion of a staphylococcal infection the child was initially
treated with intravenous amoxycilline-clavulanic acid,
which was later changed to acyclovir, vancomycin and
ceftazidime, considering the possibility of disseminated
herpes virus infection with secondary bacterial super-
infection of the skin lesions, although the relevant cul-
tures were negative.
On the 11
th day of hospitalization, and having shown
no substantial improvement, he was transferred to our
hospital. On admission he presented with a fever of
39°C, movement restriction of the left hip and multiple,
polymorphous skin lesions: deep ulcers, up to about 1
cm in diameter on the buttocks, bullous lesions on the
face and extremities, purulent ulcerations on the knees
and elbows as well as numerous crusted erosions on the
face, extremities, the perianal area and the oropharynx
(Figures 1, 2, 3). Blood leukocytosis (25,050/μl) with
neutrophilia (71%) and elevated ESR (100 mm/1
st hour)
and CRP (30 mg/l) were the main laboratory findings
(Table 1). Remarkable was the pathergy-like eruption of
cutaneous lesions at sites of minimal skin trauma, like
intravenous catheter placement. Initial clinical differen-
tial diagnoses included Sweet’ss y n d r o m ea sw e l la sa
superficial bullous variant of pyoderma gangrenosum,
Behcet’s disease and bacterial superinfection of varicella
lesions. Thus the antibiotic and antiviral treatment was
continued and the child was re-evaluated by extensive
serological tests for infectious agents and an immunol-
o g yp r o f i l e ,T z a n ks m e a r ,m i c robiological cultures of
lesional tissue samples and skin lesion biopsy. On the
second day in our department stridor suddenly
appeared, an X-ray revealed an airway constriction and
intravenous dexamethasone (0.6 mg/kg body weight)
was immediately administered. The child responded
Table 1 Laboratory findings during the course of the syndrome
Laboratory
parameters
5
th day of illness
(admission to another
hospital)
15
th day of illness
(admission to our
hospital)
17
th day of illness
(initiation of
prednisone)
20
th day of
illness
(3
rd day on
prednisone)
57
th day of illness
(termination of
prednisone)
Leukocytes
(/μl)
26,500 25,050 22,770 15,550 13,140
Neutrophils (%) 47 71 74 54 19
Lymphocytes
(%)
40 21 18 32 73
Hemoglobin
(g/dl)
11.9 9.8 9.2 9.5 14.2
Platelets (/μl) 559,000 986,000 807,000 889,000 491,000
ESR (mm/1
st
hour)
57 100 102 59 4
CRP (mg/l) 100 30 60 12 3
Blood urea
nitrogen (mg/
dl)
22 11 13 14 21
Serum
creatinine (mg/
dl)
0.5 0.4 0.4 0.4 0.5
Serum
potassium
(meq/l)
4.8 4.3 3.6 3.5 4.5
Serum sodium
(meq/l)
137 135 135 135 138
AST (IU/l) 37 46 34 27 42
ALT (IU/l) 11 17 21 22 15
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and of his general condition.
Skin lesion biopsy revealed a dense inflammatory infil-
tration of the dermis consisting mainly of mature neu-
trophils and an intense edema on the upper dermis,
findings consistent with the clinical differential diagnosis
of Sweet’s syndrome (Figure 4). Of the rest of the
laboratory evaluations, besides the serological confirma-
tion of a recent rotavirus infection (immuno-chromato-
graphic test), all tests were either negative or within
normal ranges. Based on the clinical and laboratory evi-
dence as well as the immediate response to the
Figure 1 Papular and nodular-pustular lesions on the face and right hand and partially erosive lips.
Figure 2 Centrally ulcerated papular-pustular lesions on the elbow.
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syndrome was established (Appendix). The vesicobullous
features of the rash, which are not common presenta-
tions in Sweet’s syndrome, led the differential diagnosis
to a superficial bullous variant of pyoderma
gangrenosum, probably associated with an emerging
hematological malignancy [3]. Therefore, a screening for
a concomitant malignancy (bone marrow aspirate and
trephine, chest X-ray and an abdominal ultrasound) was
performed with no abnormal findings.
Figure 3 Almost confluent ulcers on the buttocks.
Figure 4 Histopathology of a skin lesion. Spongiotic epidermis and exocytosis of neutrophils with focally confluence into microabcesses.
Intense edema of the upper dermis and a dense neutrophilic inflammatory infiltrate of the lower dermis. (Hematoxylin-Eosin, × 100).
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and intravenous prednisone (1 mg/kg body weight/24 h)
was administered for 10 days with immediate cessation
of the fever and gradual improvement of the skin
lesions, the hip complaints and the laboratory findings
(Table 1). Thereafter, prednisone was continued orally
and tapered off slowly over a period of 40 days. After
six months of follow-up no recurrence has been
observed and the child is thriving.
Discussion
We report on the case of an atypical vesicobullous var-
iant of Sweet’s syndrome in a child with a serologically
documented preceding rotavirus infection. Although
gastroenteritis often precedes an ‘idiopathic’ Sweet’s syn-
drome, this is the first, to the best of our knowledge,
documented case of an associated rotavirus infection
and this syndrome. Given (a) the high prevalence of
rotavirus infections, (b) the frequency of gastroenteritis
as a concomitant disease of the Sweet’ss y n d r o m ea n d
(c) the wide suspicion in the literature that this syn-
drome is still under-diagnosed, this is a remarkable dis-
crepancy, which calls for further exploration in future
studies.
Sweet’s syndrome was originally described in 1964 by
Douglas Sweet as an ‘acute febrile neutrophilic dermato-
sis’ [1]. Since then several cases have been reported in
the literature, most of them in adults but also in chil-
dren of all age groups [6]. In children the syndrome is
usually of the classic, ‘para-infectious’ subtype and in
most cases follows a respiratory or a gastrointestinal
infection. The most frequent nosologic entities that have
been associated with this syndrome in children are
shown in the Appendix.
Classical or idiopathic (’para-infectious’) Sweet’ss y n -
drome is characterized by fever (higher than 38°C),
blood leukocytosis and neutrophilia, which can precede
the cutaneous manifestations for several days, character-
istic skin lesions (tender erythematous papules or
nodules which can develop into erythematous plaques
with a characteristic papillomatous surface). Skin biopsy
is the laboratory test that usually confirms the clinical
diagnosis of Sweet’s syndrome. Edema and a diffuse and
perivascularly attenuated inflammatory infiltrate of
mature neutrophils with neutrophil fragmentation in the
upper dermis, yet without microscopical evidence of
vasculitis are the hallmarks of the histopathological pic-
ture [7]. The most often affected areas are the upper
extremities, the face and the neck. Sometimes the
lesions may resemble blisters, while less often, may
mimic lesions of pyoderma gangrenosum (Figure 2).
Another characteristic clinical feature is the Köbner
phenomenon, that is, appearance of ‘specific’ skin lesions
at sites of minor cutaneous trauma (biopsy,
venipuncture, and so on.). Skin lesions in Sweet’s
syndrome usually resolve without scarring.
A p a r tf r o mt h ei n v o l v e m e n to ft h ei n t e g u m e n t ,a sa
result of an extensive, multiorganic, sterile neutrophilic
inflammatory process other organic systems can be
involved as well, as the hip involvement in our patient,
probably the result of a sterile arthritis [8]. Also,
mucosal involvement is not unusual; it presents as ede-
matous and aphthous lesions of the upper aero-diges-
tive tract in the mouth and pharynx that can lead to
airway obstruction, as happened to our patient too [9].
Systemic symptoms that may coexist are headache,
myalgias and arthralgias. The syndrome may resolve
either automatically or after medication. Recurrence is
considered as the most common complication and can
take place in various time points. Quite typical is the
immediate response to systemic corticosteroids, though
after tapering off it recurs in at least one third of the
cases. Corticosteroids (prednisone, 1 mg/kg body
weight/24 h) are the treatment of choice, usually admi-
nistered for 10 days and then tapered down slowly to
avoid recurrence. However, in children the syndrome
is considered more resistant to corticosteroids than in
adults and sometimes protracted treatment for up to
five months is required in order to avoid recurrences
[10]. Topical corticosteroids can be used in patients
with localized lesions either as monotherapy or con-
currently to systemic prednisone. Potassium iodide and
colchicine have also been used with good results as
monotherapies or in combination with corticosteroids,
while indomethacin, clofazimine, cyclosporine and dap-
sone are considered as second-line modalities [11]. In
malignancy associated cases cure or remission of the
u n d e r l y i n gd i s e a s ei sf o l l o w e db yt h ec l e a r a n c eo ft h e
symptoms, while in drug induced cases spontaneous
improvement is achieved by stopping the suspected
medication.
The pathogenesis of Sweet’ss y n d r o m ei ss t i l l
unknown. Its epidemiological characteristics and the
related conditions (infections, malignancies, systemic
autoimmune conditions, inflammatory bowel diseases
and female predominance) classify this disorder among
the diseases that relate to hypersensitivity reactions to
bacterial, viral or tumor antigens or to drugs. Circulat-
ing autoantibodies, immune complexes and aberrant
expression of different cytokines have all been postu-
lated to explain the pathogenesis of this syndrome
[12,13]. According to the most recent view, the syn-
drome reflects a skin-confined or systemic disorder of
the homeostasis of the cytokine network leading to
abundance of pro-inflammatory cytokines in target tis-
s u e s ,e s p e c i a l l yo fI L - 1 ,G - C S F ,G M - C S Fa n dI F N - a .I t
is worth mentioning that rotavirus infections elicit an
increased cytokine production in the intestinal
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explain the way by which this infection probably con-
tributed to the induction of the Sweet’s syndrome in our
patient [14].
Conclusions
In conclusion, besides reporting the association between
a rotavirus infection and Sweet’ss y n d r o m ei nac h i l d ,
our case report is also a reminder that the differential
diagnosis of a febrile child with a papulo-nodular rash
and blood neutrophilia should always include Sweet’s
syndrome. In such cases thorough search for common
infectious causes and complete examination for extracu-
taneous manifestations are mandatory and, after con-
firming the diagnosis, a step-by-step examination to rule
out underlying malignancy is warranted. We think that
our report of the correlation of the syndrome with rota-
virus infection is important, as isolation of specific cau-
sative agents may help in revealing the pathophysiology
of this probably underdiagnosed syndrome.
Appendix
￿ Diagnostic criteria for classical Sweet’ss y n d r o m e
(originally proposed by Su and Liu in 1986 and mod-
ified by von den Driesch in 1994) [4,5]. For the
establishment of the diagnosis of the syndrome two
major and two of the four minor criteria are
required. Major criteria: 1. Abrupt onset of tender
erythematous plaques or nodules; 2. Dense neutro-
philic infiltrate of the dermis without leukocytoclas-
tic vasculitis. Minor criteria: 1. Fever of over 38°C; 2.
Preceding respiratory or gastrointestinal infection or
vaccination or association with an hematologic or
another malignancy, inflammatory disease or preg-
nancy; 3. Three of the following four laboratory find-
ings ESR > 20 mm/1
st hour, leukocytes > 8.000/μl,
n e u t r o p h i l s>7 0 % ,p o s i t i v eC R P ;4 .E x c e l l e n t
response to systemic corticosteroids or potassium
iodide.
￿ Conditions associated with Sweet’s syndrome in
children: upper respiratory tract illness, gastrontest-
inal infection, acute myelogenous leukemia, acute
lymphoblastic leukemia, myelodysplastic syndrome,
Fanconi’s aplastic anaemia, congenital dyserythro-
poietic anaemia, aseptic meningitis, Behchet’s
disease, Takayasu arteriitis, systemic lupus erythema-
tosus, ulcerative colitis, T-cell or humoral immuno-
deficiency, human immunodeficiency virus infection,
chronic granulomatous disease, drugs (G-CSF, reti-
noic acid).
Consent
Written informed consent was obtained from the par-
ents of the patient for publication of this case report
and accompanying images. A copy of the written con-
sent is available for review by the Editor-in-Chief of this
journal.
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